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The Ljungan (picorna) virus (LV) was first isolated in 1998 from Swedish bank voles (Myodes 
glareolus) after clinically recognizable type-1 diabetes-like symptoms were noted in this species in 
Denmark. LV has subsequently been shown to induce type-2-like diabetes, as well as uterine 
resorptions, malformations, and neonatal death in CD-1 laboratory house mice, and has been found in 
wild voles in the USA, as well as in lemmings and laboratory rats. Intriguingly, the incidence of type-
1 diabetes, Guillain-Barré syndrome and myocarditis in the human population is correlated with 
rodent population cycles in Sweden. In addition, LV has been associated with intrauterine fetal death 
in Sweden, and a preliminary study showed that children newly diagnosed with type-1 diabetes have 
significantly increased levels of LV antibodies compared to controls. It has been hypothesized that the 
bank vole as well as other small rodents could act as reservoirs and/or vectors of LV that may be a 
zoonotic agent several human diseases or pathologies, including economically important type-1 
diabetes. Consequently, knowledge of the distribution LV among wild and domestic mammal species 
is crucial to assess its potential importance as a human pathogen, identify possible zoonotic sources of 
the virus and lay groundwork for possible vaccine development. Here we provide a review of the 
current understanding of the ecopathology of LV and present the first results from southern Europe. 
Using Real Time RT PCR, LV was confirmed in 50% (10/20) of bank voles and in 10% (2/20) of 
yellow-necked mice (Apodemus flavicollis) collected from an alpine meadow in northern Italy during 
2006. LV-positive animals included males and females, adults and subadults. This is the first time LV 
has been reported in Italy and in yellow-necked mice. These results significantly increase the 
geographical and species range of LV. We believe the global distribution of this picornavirus, and its 
role as a zoonotic agent, deserve further attention. 
 
 
 
